{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:07:08Z","timestamp":1791893228664,"version":"4.3.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","painmanagementnursing.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pain Management Nursing"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pmn.2025.06.011","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T11:11:14Z","timestamp":1753096274000},"page":"e539-e544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Central vs. Peripheral Venous Oxaliplatin Administration and Chemotherapy-Induced Peripheral Neuropathy Severity"],"prefix":"10.1016","volume":"26","author":[{"given":"Tingting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3302-6023","authenticated-orcid":false,"given":"Yongkun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pmn.2025.06.011_bib0001","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(00)00667-1","article-title":"The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons","volume":"406","author":"Adelsberger","year":"2000","journal-title":"European Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.pmn.2025.06.011_bib0002","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ctrv.2008.01.003","article-title":"A review on oxaliplatin-induced peripheral nerve damage","volume":"34","author":"Argyriou","year":"2008","journal-title":"Cancer Treatment Reviews"},{"issue":"3","key":"10.1016\/j.pmn.2025.06.011_bib0003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1040-8428(01)00169-X","article-title":"Oxaliplatin: Available data in non-colorectal gastrointestinal malignancies","volume":"40","author":"B\u00e9couarn","year":"2001","journal-title":"Critical Reviews In Oncology\/hematology"},{"issue":"33","key":"10.1016\/j.pmn.2025.06.011_bib0004","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1200\/JCO.22.02773","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"41","author":"de Gramont","year":"2023","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"5 Suppl 15","key":"10.1016\/j.pmn.2025.06.011_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/sonc.2002.35525","article-title":"Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures","volume":"29","author":"Gamelin","year":"2002","journal-title":"Seminars in Oncology"},{"issue":"5","key":"10.1016\/j.pmn.2025.06.011_bib0006","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1152\/jn.2001.85.5.2293","article-title":"A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels","volume":"85","author":"Grolleau","year":"2001","journal-title":"Journal of Neurophysiology"},{"issue":"10","key":"10.1016\/j.pmn.2025.06.011_bib0008","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Annals of Oncology: Official Journal of the European Society For Medical Oncology"},{"issue":"23","key":"10.1016\/j.pmn.2025.06.011_bib0009","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1200\/JCO.2004.03.119","article-title":"Randomized multicenter phase II trial of bolus plus infusional fluorouracil\/leucovorin compared with fluorouracil\/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer","volume":"22","author":"Kemeny","year":"2004","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.pmn.2025.06.011_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mus.20340","article-title":"Oxaliplatin-induced neurotoxicity and the development of neuropathy","volume":"32","author":"Krishnan","year":"2005","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1016\/j.pmn.2025.06.011_bib0011","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mus.10559","article-title":"Oxaliplatin-induced neurotoxicity: Acute hyperexcitability and chronic neuropathy","volume":"29","author":"Lehky","year":"2004","journal-title":"Muscle & Nerve"},{"key":"10.1016\/j.pmn.2025.06.011_bib0007","first-page":"1171","article-title":"Chinesization of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in cancer patients and its reliability and validity tests","volume":"37","author":"Li","year":"2022","journal-title":"Journal of Nurses Training"},{"issue":"7","key":"10.1016\/j.pmn.2025.06.011_bib0012","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.pain.2011.02.051","article-title":"Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation","volume":"152","author":"Nassini","year":"2011","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.pmn.2025.06.011_bib0013","first-page":"619","article-title":"Chemotherapy-induced peripheral neuropathy: Pathogenesis and emerging therapies","volume":"12","author":"Ocean","year":"2004","journal-title":"Supportive Care In Cancer: Official Journal of the Multinational Association of Supportive Care In Cancer"},{"issue":"Pt 10","key":"10.1016\/j.pmn.2025.06.011_bib0014","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/brain\/awp219","article-title":"Oxaliplatin-induced neurotoxicity: Changes in axonal excitability precede development of neuropathy","volume":"132","author":"Park","year":"2009","journal-title":"Brain: A Journal of Neurology"},{"issue":"2","key":"10.1016\/j.pmn.2025.06.011_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2006.01.001","article-title":"Oxaliplatin-related neurotoxicity: How and why?","volume":"59","author":"Pasetto","year":"2006","journal-title":"Critical Reviews In Oncology\/hematology"},{"issue":"10","key":"10.1016\/j.pmn.2025.06.011_bib0016","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00520-024-08807-6","article-title":"Oxaliplatin-induced peripheral neuropathy with hepatic arterial versus intravenous infusion in metastatic colorectal cancer","volume":"32","author":"Val\u00e9ry","year":"2024","journal-title":"Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"7","key":"10.1016\/j.pmn.2025.06.011_bib0017","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2002.07.056","article-title":"Acute oxaliplatin-induced peripheral nerve hyperexcitability","volume":"20","author":"Wilson","year":"2002","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"}],"container-title":["Pain Management Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1524904225002024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1524904225002024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:10:23Z","timestamp":1763766623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1524904225002024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1524904225002024"],"URL":"https:\/\/doi.org\/10.1016\/j.pmn.2025.06.011","relation":{},"ISSN":["1524-9042"],"issn-type":[{"value":"1524-9042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central vs. Peripheral Venous Oxaliplatin Administration and Chemotherapy-Induced Peripheral Neuropathy Severity","name":"articletitle","label":"Article Title"},{"value":"Pain Management Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmn.2025.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pain Management Nursing.","name":"copyright","label":"Copyright"}]}}